Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

Lung cancer is the leading cause of cancer‐associated death, and non‐small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases. Many drugs have been used to treat NSCLC in order to improve patient prognosis. Platinum‐based chemotherapy is the first‐line treatment for locally advanced...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Thorac Cancer
Asıl Yazarlar: Wang, Leirong, Ma, Leina, Xu, Fei, Zhai, Wenxin, Dong, Shenghua, Yin, Ling, Liu, Jia, Yu, Zhuang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons Australia, Ltd 2018
Konular:
Mini Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026617/
https://ncbi.nlm.nih.gov/pubmed/29726094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12652
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller